Type 1 Diabetes in Focus: Optimizing Outcomes with Early Intervention : Episode 2

C-Peptide and Early Type 1 Diabetes Detection

April 4, 2025

Opinion

Video

A panelist discusses how C-peptide serves as a critical biomarker of endogenous insulin production, providing clinicians with valuable insights into remaining beta cell function that can guide personalized treatment approaches and help predict disease progression in patients with type 1 diabetes (T1D).

EP: 1.Type 1 Diabetes: Understanding Disease Progression and Beta Cell Function

Now Viewing

EP: 2.C-Peptide and Early Type 1 Diabetes Detection

EP: 3.Advancing Early Detection: Autoimmune Screening in Type 1 Diabetes

EP: 4.Misdiagnosis of Type 1 Diabetes in Adults: Prevalence, Causes and Consequences

EP: 5.Preserving Beta Cell Function in T1D: Current Strategies and Emerging Therapies

EP: 6.Final Thoughts on Type 1 Diabetes: Innovations, Challenges and the Road Ahead

EP: 7.Type 1 Diabetes in Focus: Optimizing With Early Interventions | Written Recap

Video content above is prompted by the following:

C-peptide is increasingly recognized as a marker for beta cell function. Can you explain the role of C-peptide in practice?
How does early identification of T1D change the trajectory of disease management?

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!